The collaboration will leverage Iambicās AI-driven drug discovery platform, including its flagship AI technologies, Enchant & NeuralPLexer, to identify novel drug entry points and differentiated molecules to address otherwise hard-to-drug targets that will enhance Bayerās early portfolio.
FBI Reform - fbireform.comFBI Reform - fbireform.com - The News And Times